Regenxbio
RGNX
RGNX
171 hedge funds and large institutions have $717M invested in Regenxbio in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.54% more ownership
Funds ownership: 84.26% → 90.8% (+6.5%)
14% less call options, than puts
Call options by funds: $1.74M | Put options by funds: $2.02M
23% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 61
Holders
171
Holding in Top 10
3
Calls
$1.74M
Puts
$2.02M
Top Buyers
| 1 | +$58.5M | |
| 2 | +$21.3M | |
| 3 | +$6.15M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$5.83M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.92M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$10.3M | |
| 3 | -$9.14M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$8.17M |
| 5 |
Goldman Sachs
New York
|
-$4.68M |